| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/17/2004 | US6692743 Apoptosis of naive human NK cells by crosslinking of their FcγRIIIa molecules with a rat IgG2b (LO-CD2a/BTI-322) or its IgG1 humanized monoclonal antibody |
| 02/17/2004 | US6692741 Treatment of acute lung injury and fibrosis with antagonists of β6-specific antibodies |
| 02/17/2004 | US6692740 Nucleotide sequences coding polypeptide for use in the treatment of arthritis, osteoporosis, liver, diabetic and inflammatory bowel diseases |
| 02/17/2004 | US6692737 In vivo protein production and delivery system for gene therapy |
| 02/17/2004 | US6692736 Replication-competent adenovirus vector including two genes co-transcribed as single mrna under transcriptional control of heterologous target cell-specific transcriptional regulatory element; one has mutation or deletion of endogenous promoter |
| 02/17/2004 | US6692735 Truncated variant of c6 beta-chemokine leukotactin-1 polypeptide consisting of specified amino acid sequence |
| 02/17/2004 | CA2143325C Cloning and expression of .beta.app-c100 receptor |
| 02/17/2004 | CA2112667C Monoclonal antibodies to putative hcv ns5 proteins and methods for using same |
| 02/17/2004 | CA2075288C Anthracycline-conjugates |
| 02/12/2004 | WO2004013636A2 Differential labeling for quantitative analysis of complex protein mixtures by trifunctional synthetic peptide based reagents with iodoacetamido groups |
| 02/12/2004 | WO2004013631A2 Compositions and methods for diagnosis and therapy of cancer |
| 02/12/2004 | WO2004013609A2 Use of biomarkers for detecting ovarian cancer |
| 02/12/2004 | WO2004013356A1 Compositions, methods, and kits relating to behab and primary cns tumors |
| 02/12/2004 | WO2004013347A2 Methods of identifying compounds that modulate protein activity |
| 02/12/2004 | WO2004013343A2 Use of lactobacillus to produce exopolysaccharides in food and pharmaceutical compositions |
| 02/12/2004 | WO2004013331A1 Pathogenic genes of xanthomonas oryzae pv. oryzae and utilization thereof |
| 02/12/2004 | WO2004013330A1 Multifunctional genetic constructions having a high capacity to inhibit the expression of ccr5 on the cell surface |
| 02/12/2004 | WO2004013327A1 Method for the expression of unknown environmental dna into adapted host cells |
| 02/12/2004 | WO2004013326A1 Cartilage differentiation inhibiting gene |
| 02/12/2004 | WO2004013325A1 Method of detecting mouse interferon-producing cells |
| 02/12/2004 | WO2004013318A1 Method for inducing complete hepatitis c virus (hcv) replication in vitro |
| 02/12/2004 | WO2004013311A2 Compositions and methods relating to ovarian specific genes and proteins |
| 02/12/2004 | WO2004013309A2 PAPSSs AS MODIFIERS OF THE AXIN PATHWAY AND METHODS OF USE |
| 02/12/2004 | WO2004013308A2 Maxs as modifiers of the axin pathway and methods of use |
| 02/12/2004 | WO2004013307A2 Compounds for targeting hepatocytes |
| 02/12/2004 | WO2004013306A2 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 02/12/2004 | WO2004013304A2 Sugar and lipid metabolism regulators in plants iv |
| 02/12/2004 | WO2004013303A2 Modified annexin proteins and methods for treating vaso-occlusive sickle-cell disease |
| 02/12/2004 | WO2004013302A2 CARD11 NFkB ACTIVATING POLYPEPTIDES, NUCLEIC ACIDS, INBRED AND TRANSGENIC ANIMALS, AND METHODS OF USE THEREOF |
| 02/12/2004 | WO2004013301A2 Seed-associated promoter sequences |
| 02/12/2004 | WO2004013297A2 Manzamine-producing actinomycetes |
| 02/12/2004 | WO2004013295A2 Plant rna binding protein, encoding nucleic acids, and methods of use |
| 02/12/2004 | WO2004013294A2 Method of producing non-recombinant bmp-2 and use thereof |
| 02/12/2004 | WO2004013293A2 Transporters and ion channels |
| 02/12/2004 | WO2004013292A2 Extracellular messengers |
| 02/12/2004 | WO2004013289A2 Diagnosis of kidney damage and protection against same |
| 02/12/2004 | WO2004013285A2 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 02/12/2004 | WO2004013281A2 Novel proteins and their uses |
| 02/12/2004 | WO2004013279A2 Helix-hairpin-helix motifs to manipulate properties of dna processing enzymes |
| 02/12/2004 | WO2004013179A1 Conjugate of notch signalling pathway modulators and their use in medical treatment |
| 02/12/2004 | WO2004013178A1 Fusion proteins between a fluorescent protein and an ionotropic receptor and uses thereof |
| 02/12/2004 | WO2004013177A1 Modulation of upa-mediated functions via the aminoterminal fragment of mannose-6-phosphate/insuline-like growth factor 2 receptor (cd222) |
| 02/12/2004 | WO2004013176A1 Method for purifying preproinsulin |
| 02/12/2004 | WO2004013175A1 SYNTHETIC GENE CODING FOR HUMAN GRANULOCYTE-COLONY STIMULATING FACTOR FOR THE EXPRESSION IN E. coli |
| 02/12/2004 | WO2004013174A1 Use of disease-associated gene |
| 02/12/2004 | WO2004013173A1 Novel potassium-dependent sodium-calcium exchanger |
| 02/12/2004 | WO2004013172A2 Fragments of beta-amyloid as targets for vaccination against alzheimer disease |
| 02/12/2004 | WO2004013169A1 Corn root preferential promoters and uses thereof |
| 02/12/2004 | WO2004013168A2 Protein containing a burp domain |
| 02/12/2004 | WO2004013166A2 S. aureus antigene |
| 02/12/2004 | WO2004013165A1 Pegylated t1249 polypeptide |
| 02/12/2004 | WO2004013164A1 Pegylated t20 polypeptide |
| 02/12/2004 | WO2004013160A2 Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof |
| 02/12/2004 | WO2004013151A2 Campylobacter glycans and glycopeptides |
| 02/12/2004 | WO2004012817A2 Use of genes identified to be involved in tumor development for the development of anti-cancer drugs |
| 02/12/2004 | WO2004012758A1 Use of tgf beta ig-h3 for preventing and treating obesity, diabetes and/or metabolic syndrome |
| 02/12/2004 | WO2004012681A2 Cancer vaccines containing epitopes of oncofetal antigen |
| 02/12/2004 | WO2004012675A2 Lipid binding molecules and methods of use |
| 02/12/2004 | WO2004012673A2 Methods and reagents relating to inflammation and apoptosis |
| 02/12/2004 | WO2004012668A2 Sodium channel alpha subunit variants |
| 02/12/2004 | WO2004012660A2 Mk2 interacting proteins |
| 02/12/2004 | WO2004012588A2 Use of biomarkers for detecting ovarian cancer |
| 02/12/2004 | WO2004012574A2 Negative selections assays, and compositions thereof |
| 02/12/2004 | WO2004012504A1 Miglur5 metabotropic glutamate receptor gene disruptions, and com positions and methods related thereto |
| 02/12/2004 | WO2003104400A3 Secretory signal sequences and uses thereof |
| 02/12/2004 | WO2003103570A3 Transcutaneous immunization against papillomavirus with papillomavirus virus-like particles |
| 02/12/2004 | WO2003100061A3 Three finger toxin fold proteins |
| 02/12/2004 | WO2003093316A3 Immunoglobulin-domain containing cell surface recognition molecules |
| 02/12/2004 | WO2003093307A8 Mycobacterial antigens and uses thereof |
| 02/12/2004 | WO2003093306A3 Nucleic acids and proteins from streptococcus groups a & b |
| 02/12/2004 | WO2003091414A3 Adipocyte complement related protein zacrp8 |
| 02/12/2004 | WO2003091384A3 A role for survivin in apoptosis of myeloid cells |
| 02/12/2004 | WO2003089584A3 Use of parapox b2l protein to modify immune responses to administered antigens |
| 02/12/2004 | WO2003089454A3 Unnatural amino acid containing display libraries |
| 02/12/2004 | WO2003087150A3 Novel fluorescent proteins containing fqygf in the chromophore |
| 02/12/2004 | WO2003082329A3 Compositions and compounds for use as molecular adjuvant for a nicotine vaccine |
| 02/12/2004 | WO2003076365A3 Materials and methods for controlling pests |
| 02/12/2004 | WO2003072789A3 Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors |
| 02/12/2004 | WO2003072037A3 High-level production of amyloid-beta peptides from imr-32 cells |
| 02/12/2004 | WO2003070769A3 Organic compounds having anti-angiogenic activity |
| 02/12/2004 | WO2003066869A8 Lmt tumor suppressor gene |
| 02/12/2004 | WO2003064463B1 Pluripotency determining factors and uses thereof |
| 02/12/2004 | WO2003064453A3 Trojan inhibitors, method for the production and use thereof |
| 02/12/2004 | WO2003060066A3 Nucleic acid delivery and expression |
| 02/12/2004 | WO2003057158A3 Method of treating apoptosis and compositions thereof |
| 02/12/2004 | WO2003050301A3 Susceptibility locus for schizophrenia |
| 02/12/2004 | WO2003050141B1 Calpain activators |
| 02/12/2004 | WO2003048312A3 TUMOR SUPPRESSORS ASSOCIATED WITH HUMAN CHROMOSOME 21q22 |
| 02/12/2004 | WO2003046123A3 Mutated gene from corynebacterium glutamicum |
| 02/12/2004 | WO2003044041A3 Alpha-fetoprotein peptides and uses for imaging |
| 02/12/2004 | WO2003040094A3 Methods for preparation of macrocyclic molecules macrocyclic molecules prepared thereby and substrates and solid supports for use therein |
| 02/12/2004 | WO2003039346A3 Diagnostics and therapeutics for ocular abnormalities |
| 02/12/2004 | WO2003031650A3 Genes and proteins for prevention, prediction, prognosis and therapy of cardiovascular disease |
| 02/12/2004 | WO2003031589A8 Peptides and related compounds having thrombopoietic activity |
| 02/12/2004 | WO2003029416A3 Recombinant respiratory syncytial viruses with deleted surface glycoprotein genes and uses thereof |
| 02/12/2004 | WO2003027276A3 Novel compositions and methods for diagnosis and treatment of lymphoma and leukemia |
| 02/12/2004 | WO2003026390A3 Plant reproduction polynucleotides and methods of use |
| 02/12/2004 | WO2003025010A3 Human delta-n p73 molecules and uses thereof |
| 02/12/2004 | WO2003022225A3 Compositions comprising mixtures of therapeutic proteins and methods of producing the same |
| 02/12/2004 | WO2003020906A3 Multivalent protein conjugate with multiple ligand-binding domains of receptors |